NCT06514586View on ClinicalTrials.gov

The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

244

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

August 31, 2025

Conditions

Vaginal AtrophyGenitourinary Syndrome of MenopauseVulvar Atrophy

Interventions

DRUG

Oxytocin

Oxytocin gel 600 IU . 1mg/g

OTHER

Hydroxypropyl methylcellulose

Placebo

Trial Locations (1)

Unknown

Oxagon, Cairo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Oxagon

NETWORK